STACKD summary
Limited human dataGHK-Cu and skin remodeling
Topical skin research is the strong part—injectable claims are not.
Plain-language summary
GHK-Cu is a small copper-carrying peptide with a real history in skin science. In cosmetic and dermatology research, topical GHK-Cu has been studied for skin appearance and remodeling. The disconnect online is that people take topical skin findings and stretch them into systemic, injectable recovery claims—a route the strong evidence doesn't actually cover.
What was studied
Primarily dermatology / cosmetic-science literature on topical GHK-Cu and skin remodeling, plus mechanistic reviews on how the copper complex may influence remodeling, antioxidant defense, and the extracellular matrix.
Key takeaways
- The best-supported context is topical use for skin appearance and remodeling.
- Copper binding is central to most of the proposed mechanisms.
- Route of administration matters enormously here—topical evidence does not validate injectable narratives.
- Evidence tier is “limited human,” weighted toward skin endpoints.
Limitations & what we don't know
- Systemic/injectable claims popular online are far less supported than topical skin research.
- Copper load and product quality are practical safety considerations.
- Marketing endpoints often differ from peer-reviewed endpoints.
- Recovery/tissue-quality claims beyond skin are largely extrapolation.
Sources
Primary citations behind this summary. External links are provided for verification—read them yourself before drawing conclusions.
- 1.The human copper-binding peptide GHK-Cu in skin remodeling and anti-aging
2018 · review
Reviews proposed skin-remodeling roles.